EP1392657A4 - PROTEASE INHIBITORS - Google Patents

PROTEASE INHIBITORS

Info

Publication number
EP1392657A4
EP1392657A4 EP01275089A EP01275089A EP1392657A4 EP 1392657 A4 EP1392657 A4 EP 1392657A4 EP 01275089 A EP01275089 A EP 01275089A EP 01275089 A EP01275089 A EP 01275089A EP 1392657 A4 EP1392657 A4 EP 1392657A4
Authority
EP
European Patent Office
Prior art keywords
protease inhibitors
protease
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01275089A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1392657A2 (en
Inventor
Robert W Marquis Jr
Daniel F Veber
Dennis S Yamashita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP1392657A2 publication Critical patent/EP1392657A2/en
Publication of EP1392657A4 publication Critical patent/EP1392657A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
EP01275089A 2000-11-22 2001-11-19 PROTEASE INHIBITORS Withdrawn EP1392657A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25250800P 2000-11-22 2000-11-22
US252508P 2000-11-22
PCT/US2001/051647 WO2003053331A2 (en) 2000-11-22 2001-11-19 Protease inhibitors

Publications (2)

Publication Number Publication Date
EP1392657A2 EP1392657A2 (en) 2004-03-03
EP1392657A4 true EP1392657A4 (en) 2004-03-10

Family

ID=22956303

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01275089A Withdrawn EP1392657A4 (en) 2000-11-22 2001-11-19 PROTEASE INHIBITORS

Country Status (17)

Country Link
EP (1) EP1392657A4 (zh)
JP (1) JP2005513083A (zh)
KR (1) KR20040004445A (zh)
CN (1) CN1635903A (zh)
AR (1) AR034278A1 (zh)
AU (1) AU2001298052A1 (zh)
BR (1) BR0115473A (zh)
CA (1) CA2436850A1 (zh)
CZ (1) CZ20031403A3 (zh)
HU (1) HUP0301964A3 (zh)
IL (1) IL155997A0 (zh)
MX (1) MXPA03004542A (zh)
NO (1) NO20032328L (zh)
PL (1) PL366232A1 (zh)
UY (1) UY27032A1 (zh)
WO (1) WO2003053331A2 (zh)
ZA (1) ZA200303848B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
CN1416346A (zh) 2000-03-21 2003-05-07 史密丝克莱恩比彻姆公司 蛋白酶抑制剂
AU2001268407A1 (en) * 2000-06-14 2001-12-24 Smithkline Beecham Corporation Protease inhibitors
CN101970007A (zh) 2007-06-08 2011-02-09 日本化学医药株式会社 脑动脉瘤的治疗或预防药
JPWO2009054454A1 (ja) 2007-10-24 2011-03-03 国立大学法人 東京医科歯科大学 カテプシン阻害剤を有効成分として含有するＴｏｌｌ様受容体のシグナル伝達の調整剤

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000038687A1 (en) * 1998-12-23 2000-07-06 Smithkline Beecham Corporation Protease inhibitors
WO2001095911A1 (en) * 2000-06-14 2001-12-20 Smithkline Beecham Corporation Protease inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1416346A (zh) * 2000-03-21 2003-05-07 史密丝克莱恩比彻姆公司 蛋白酶抑制剂

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000038687A1 (en) * 1998-12-23 2000-07-06 Smithkline Beecham Corporation Protease inhibitors
WO2001095911A1 (en) * 2000-06-14 2001-12-20 Smithkline Beecham Corporation Protease inhibitors

Also Published As

Publication number Publication date
CZ20031403A3 (cs) 2003-10-15
UY27032A1 (es) 2002-07-31
WO2003053331A3 (en) 2003-11-13
MXPA03004542A (es) 2003-09-10
JP2005513083A (ja) 2005-05-12
PL366232A1 (en) 2005-01-24
EP1392657A2 (en) 2004-03-03
WO2003053331A2 (en) 2003-07-03
HUP0301964A2 (en) 2007-02-28
CN1635903A (zh) 2005-07-06
NO20032328L (no) 2003-07-02
KR20040004445A (ko) 2004-01-13
AU2001298052A1 (en) 2003-07-09
IL155997A0 (en) 2003-12-23
CA2436850A1 (en) 2003-07-03
NO20032328D0 (no) 2003-05-22
BR0115473A (pt) 2004-09-28
ZA200303848B (en) 2004-06-28
AR034278A1 (es) 2004-02-18
HUP0301964A3 (en) 2007-09-28

Similar Documents

Publication Publication Date Title
AU4344101A (en) Protease inhibitors
GB0125445D0 (en) Protease Inhibitors
IL215890A0 (en) Peptidomimetic protease inhibitors
IL153421A0 (en) Protease inhibitors
EP1235577A4 (en) PROTEASE INHIBITORS
EP1232155A4 (en) PROTEASE INHIBITORS
IL151087A0 (en) Protease inhibitors
EP1229912A4 (en) PROTEASE INHIBITORS
EP1231921A4 (en) PROTEASE INHIBITORS
EP1229915A4 (en) PROTEASE INHIBITORS
EP1229914A4 (en) PROTEASE INHIBITORS
EP1233771A4 (en) PROTEASE INHIBITORS
EP1351930A4 (en) PROTEASE INHIBITORS
EP1173429A4 (en) PROTEASE INHIBITORS
EP1161237A4 (en) PROTEASE INHIBITORS
EP1229911A4 (en) PROTEASE INHIBITORS
EP1401453A4 (en) PROTEASE INHIBITORS
EP1231923A4 (en) PROTEASE INHIBITORS
IL155997A0 (en) Protease inhibitors
IL155961A0 (en) Cysteine protease inhibitors
EP1231922A4 (en) PROTEASE INHIBITORS
EP1232154A4 (en) PROTEASE INHIBITORS
AU6407701A (en) Serine protease inhibitors
GB0009123D0 (en) Protease inhibitor
ZA200207478B (en) Protease inhibitors.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030620

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20040127

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 31/55 B

Ipc: 7C 07D 495/04 B

Ipc: 7C 07D 405/14 B

Ipc: 7C 07D 223/08 A

18D Application deemed to be withdrawn

Effective date: 20040414

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1063632

Country of ref document: HK

D18D Application deemed to be withdrawn (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

R18D Application deemed to be withdrawn (corrected)

Effective date: 20050531

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1063632

Country of ref document: HK